Levy Adam D. (CIK 2061876) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-06). Recent activity: Sell ACRV (1,142 shares), Buy ACRV (46,167 shares), Buy ACRV (8,832 shares), Sell ACRV (1,164 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-06 | Acrivon Therapeutics, Inc. (ACRV) | Chief Financial Officer | Sell | 1,142 | $1,793 |
| 2026-05-20 | Acrivon Therapeutics, Inc. (ACRV) | Chief Financial Officer | Buy | 46,167 | $0 |
| 2026-01-16 | Acrivon Therapeutics, Inc. (ACRV) | Chief Financial Officer | Buy | 8,832 | $15,014 |
| 2025-08-05 | Acrivon Therapeutics, Inc. (ACRV) | Chief Financial Officer | Sell | 1,164 | $1,467 |
来源：SEC Form 4 申报文件 · 截至 2026-08-06